MEDICAL INTELLIGENCE GROUP LTD

Name

MEDICAL INTELLIGENCE GROUP LTD

Website

https://mig-health.com

Company type

Private

Founded year

2020

Ownership category

akta.pro rank

Product category

Digital Health Software

NAICS

Software Publishers (5132)

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD)

akta.pro secondary industries

Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO), Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

Keywords

• AI digital health tools
• Disease prevention software
• Diabetic foot ulcer management
• Healthcare AI solutions
• Digital therapeutics platform

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Core offering

Medical Intelligence Group develops AI-driven digital health tools focused on disease prevention and the management of diabetic foot ulcers. The company builds software products aimed at supporting clinical workflows related to chronic disease risk identification and patient monitoring in the diabetic care continuum.

Differentiator

Problem solved

Functional benefit

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Emerging players

• Tidepool: Tidepool offers diabetes data software and decision-support tools that aggregate device data for clinicians, comparable as a digital health data and decision-support platform in diabetes.
• Vivante Health: Vivante Health delivers digital digestive and chronic-condition care programs, providing a peer in AI-driven virtual care for chronic disease management that competes for similar employer/payer contracts.

Broad incumbents

• Omada Health: Omada is a leading virtual-care platform for chronic conditions including diabetes prevention and management, providing a broader, more established digital health incumbent that competes for the same prevention budgets.
• DarioHealth: DarioHealth is a digital chronic-condition management platform with a strong diabetes franchise, comparable as a multi-condition AI-enabled digital health incumbent.
• mySugr (Roche): mySugr, owned by Roche, is a widely used diabetes self-management app with AI-driven coaching, representing an incumbent digital diabetes competitor to Medical Intelligence Group.

Direct peers

• Podimetrics: Podimetrics builds a smart mat and AI platform for early detection of diabetic foot ulcers, the most direct comparable to Medical Intelligence Group's AI-driven DFU management focus.
• Orpyx Medical Technologies: Orpyx makes sensor-insoles and a digital platform to prevent diabetic foot complications through continuous monitoring, directly comparable to AI-enabled DFU management.
• Siren: Siren develops smart socks with embedded temperature sensors and AI to monitor diabetic foot health and prevent ulcers, overlapping directly with Medical Intelligence Group's DFU prevention thesis.
• Glooko: Glooko provides a diabetes data management platform aggregating data from devices and apps, comparable to Medical Intelligence Group's role as a digital health layer for diabetes patients.
• WellDoc: WellDoc offers FDA-cleared digital therapeutics for diabetes management, making it a close peer in the AI-driven diabetes digital health space Medical Intelligence Group operates in.

Market position

Customer concentration

• LinkedInlinkedin.com/company/medical-intelligence-group

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDICAL INTELLIGENCE GROUP LTD